Showing results (1541-1550 of 1,588) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|May 17, 2023
Association of Somatic ATP2A2 Damaging Variants With Grover DiseaseDevin Seli, Katharine T Ellis, Mohamad Goldust, et al.
JAMA Dermatology|August 22, 2020
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic ReviewMarieke E C van Winden, Lara S van der Schoot, Mariluz van de L'Isle Arias, et al.
JAMA Dermatology|August 22, 2020
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic ReviewMegan Lam, Jie Wei Zhu, Talha Maqbool, et al.
JAMA Dermatology|April 12, 2023
Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical StructuresAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.
JAMA Dermatology|April 7, 2021
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical TrialFania Z Muñoz-Garza, Mónica Ríos, Esther Roé-Crespo, et al.
JAMA Dermatology|March 31, 2021
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile HemangiomaEsteban Fernández Faith, Sonal Shah, Patricia M Witman, et al.
JAMA Dermatology|August 13, 2025
In Vivo Evaluation of Melasma Pathologic Features and Treatment Response by 2-Photon MicroscopyXiaoli Ning, Jungang Yang, Hongfei Ouyang, et al.
JAMA Dermatology|October 29, 2025
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the USChelsea N Campbell, Matthew S Krantz, Alexis Yu, et al.
JAMA Dermatology|October 22, 2025
T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell LymphomaLiliana L Crisan, Shanpeng J Li, Michelle Afkhami, et al.
JAMA Dermatology|July 9, 2025
Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical TrialsJoseph F Merola, Kim A Papp, Atul Deodhar, et al.
Pageof 159